{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_015379.5:c.6056G>A",
          "cDNA Change": {
            "transcript": "NM_015379.5",
            "ref": "G",
            "alt": "A",
            "position": "6056"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "p.G2019S"
        }
      ]
    },
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000340.3:c.158C>T",
          "cDNA Change": {
            "transcript": "NM_000340.3",
            "ref": "C",
            "alt": "T",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "V",
            "position": "53"
          },
          "Description in input context": "p.A53T"
        }
      ]
    },
    {
      "Gene": "MAPT",
      "variants": [
        {
          "HGVS": "NM_001127657.2:c.835A>G",
          "cDNA Change": {
            "transcript": "NM_001127657.2",
            "ref": "A",
            "alt": "G",
            "position": "835"
          },
          "Protein Change": {
            "ref": "N",
            "alt": "K",
            "position": "279"
          },
          "Description in input context": "p.N279K"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0016256"
  },
  "Experiment Method": [
    {
      "Assay Method": "Immunoblotting",
      "Material used": {
        "Material Source": "Patients Derived Material",
        "Material Name": "Human brain tissue from Parkinson's patients and controls",
        "Description": "Immunoblotting was performed on human brain tissue samples from Parkinson's disease patients and healthy controls."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_015379.5:c.6056G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The p.G2019S variant in LRRK2 showed increased kinase activity compared to wild-type LRRK2."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 protein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used to compare kinase activity between wild-type and mutant LRRK2."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "LRRK2 kinase activity within 10% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "LRRK2 kinase activity exceeding 20% of wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunohistochemistry",
      "Material used": {
        "Material Source": "Patients Derived Material",
        "Material Name": "Brain tissue from patients with SNCA p.A53T and controls",
        "Description": "Immunohistochemistry was performed on brain tissue samples from patients with the SNCA p.A53T variant and healthy controls."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000340.3:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The p.A53T variant in SNCA showed increased alpha-synuclein aggregation compared to wild-type SNCA."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type SNCA protein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Chi-square test was used to compare the frequency of alpha-synuclein aggregation between wild-type and mutant SNCA."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Alpha-synuclein aggregation within 5% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Alpha-synuclein aggregation exceeding 15% of wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunohistochemistry",
      "Material used": {
        "Material Source": "Patients Derived Material",
        "Material Name": "Brain tissue from patients with MAPT p.N279K and controls",
        "Description": "Immunohistochemistry was performed on brain tissue samples from patients with the MAPT p.N279K variant and healthy controls."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001127657.2:c.835A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The p.N279K variant in MAPT showed increased tau phosphorylation compared to wild-type MAPT."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type MAPT protein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Chi-square test was used to compare the frequency of tau phosphorylation between wild-type and mutant MAPT."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Tau phosphorylation within 5% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Tau phosphorylation exceeding 15% of wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}